117 related articles for article (PubMed ID: 1018876)
1. [High levels of digoxin encountered in patients with chronic uremia undergoing a periodic hemodialytic treatment and conservative therapy].
Filoramo F; Redaelli B; Pincella G; Sforzini S; Limido D; D'Amico P; Valagussa F
Minerva Nefrol; 1976; 23(5):393-6. PubMed ID: 1018876
[No Abstract] [Full Text] [Related]
2. [Studies on the serum lipid pattern in patients with chronic uremia during conservative and hemodialytic treatment].
Tarchini RG; Guarnieri GF; Baroni C; Campanacci L
Minerva Nefrol; 1974; 21(6):415-21. PubMed ID: 4462026
[No Abstract] [Full Text] [Related]
3. [Study of plasma renin activity in uremic patients undergoing periodic hemodialytic treatment].
Pigliucci GM; Suraci V; Alcini E
Chir Patol Sper; 1974 Apr; 22(2):89-97. PubMed ID: 4434788
[No Abstract] [Full Text] [Related]
4. [Hemodynamic evaluation of chronic uremic patients undergoing periodical hemodialytic treatment].
Lojacono L; Butti A; Castagneto M; Cagossi M; Salerni B; Pigliucci GM; Alquati P
Chir Patol Sper; 1970 Dec; 18(5):411-33. PubMed ID: 5525552
[No Abstract] [Full Text] [Related]
5. [Determination of plasma gastrin in patients with chronic uremia undergoing hemodialytic treatment].
Splendiani G; D'Allessandro V; Acitelli S
Minerva Nefrol; 1976; 23(5):343-6. PubMed ID: 1018869
[No Abstract] [Full Text] [Related]
6. [Research on some factors of hemostasis in patients with chronic uremia during conservative and dialytic therapy].
Fiorio P; Muttini P; Lamperi S
Minerva Nefrol; 1975; 22(2-3):83-7. PubMed ID: 1226254
[No Abstract] [Full Text] [Related]
7. [Research on some erythrocytic abnormalities in chronic uremic patients in conservative and dialytic therapy].
Lamperi S; Sitia L; Bandiani G; Muttini P
Minerva Nefrol; 1970; 17(6):175-80. PubMed ID: 5516050
[No Abstract] [Full Text] [Related]
8. [The visual apparatus in the chronic uremic patient during periodic hemodialytic treatment. II. Changes in ocular refraction during hemodialysis].
Ambrosio A; Sorice PS; Tufano L; Tonna G; Esposito E
Rass Int Clin Ter; 1971 Jul; 51(13):789-95. PubMed ID: 5568452
[No Abstract] [Full Text] [Related]
9. [Verapamil-induced digoxin poisoning in uremia].
Johannessen AC; Poulsen S
Ugeskr Laeger; 1985 May; 147(19):1547-8. PubMed ID: 4012876
[No Abstract] [Full Text] [Related]
10. [The use of nifedipine in the treatment of hypertensive crises in patients with chronic uremia undergoing periodic hemodialysis].
Russo G; Petrucci V; Spaziani M; Zarelli C; Ferazzoli F; Scarpellini MG
Clin Ter; 1985 Jan; 112(1):37-44. PubMed ID: 4017451
[No Abstract] [Full Text] [Related]
11. [The influence of twice-weekly hemodialytic treatment on the hypertensive syndrome in chronic uremic patients].
Cioni L; Biagini M; Gloria E; Pentimone F
Minerva Nefrol; 1966; 13(4):112-5. PubMed ID: 5995530
[No Abstract] [Full Text] [Related]
12. [Recent advances and prospects in periodic hemodialytic treatment for patients with uremia].
Campanacci L; Huber W
Minerva Med; 1976 Jul; 67(34):2151-60. PubMed ID: 59909
[TBL] [Abstract][Full Text] [Related]
13. [Dopamine 17-beta-hydroxylase in chronic uremic patients under periodic hemodialytic treatment].
Cagossi M; Pigliucci GM; Ruvolo MR; Porcelli G
Chir Patol Sper; 1979 Dec; 27(6):579-89. PubMed ID: 400642
[No Abstract] [Full Text] [Related]
14. [Control by means of Computer control of the hematochemical picture in chronic uremic patients undergoing periodic hemodialysis treatment].
Novario PG; Pagliano B; Denti E; Segoloni G; Piccoli G; Vercellone A; Coppo R
Minerva Nefrol; 1974; 21(5):347-59. PubMed ID: 4467056
[No Abstract] [Full Text] [Related]
15. [Exchangeable sodium, water spaces, blood renin and arterial pressure in a group of chronic uremics in periodic hemodialytic therapy, undergoing binephrectomy].
Romagnoli GF; Borsatti A; Giongo A; Muolo A; Huber W; Galvani E; Guarnieri GF; Mioni G
G Clin Med; 1969 Dec; 50(12):1197-206. PubMed ID: 5386468
[No Abstract] [Full Text] [Related]
16. [Treatment using polystyrolsulfonic resin in the calcic stage of hyperkalemia in subjects with chronic uremia receiving and not receiving a periodic hemodialysis treatment].
Sorice PS; Esposito E; Tufano L; Dell'Aversano MR
Minerva Nefrol; 1971; 18(6):302-8. PubMed ID: 5173641
[No Abstract] [Full Text] [Related]
17. [Quinbolone in the therapy of anemia in uremic patients during periodic hemodialytic treatment].
Amato M; Bigioli F; Beconi D; Martinelli F; Lapini V; Salvadori M
Clin Ter; 1980 Jul; 94(1):57-65. PubMed ID: 7438723
[No Abstract] [Full Text] [Related]
18. [Short-term effect of treatment with oral DL-carnitine and intravenous L-carnitine in chronic uremia patients undergoing hemodialytic therapy].
Demelia L; Solinas A; Gogoni G; Marongiu F; Besson A
Recenti Prog Med; 1982 May; 72(5):664-74. PubMed ID: 6753066
[No Abstract] [Full Text] [Related]
19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
20. [Cimetidine in the therapy of secondary hyperparathyroidism in uremia with hemodialytic treatment].
Antonucci F; Gropuzzo M; Messa P; Montanaro D; Adorati M; Paviotti G; Favazza A; Susanna F; Zilli M; Messa M
Minerva Nefrol; 1983; 30(3):133-9. PubMed ID: 6646487
[No Abstract] [Full Text] [Related]
[Next] [New Search]
